logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Sarepta Pharmaceuticals Jumps on Competitor’s Failure

  +Follow August 16, 2013 9:54AM
Share:
Tickers Mentioned:

Sarepta Therapeutics Inc. (SRPT) experienced a bit of schadenfreude on Aug. 16 as a direct competitor stumbled badly at the finish line.

Competitor GlaxoSmithKline plc (GSK) had been neck-and-neck with Serepta in the race to develop a breakthrough muscle disorder drug to treat Duchenne Muscular Dystrophy. Both drugs were far ahead of the pack in the development process.

That is, until Baird analyst Brian Skorney reported that Glaxo’s drug, drisapersen, has encountered major stumbling blocks on several fronts that could significantly hamper development. Skorney cited clinical, regulatory, and commercials issues with the drug. Most importantly, the drug did not seem to effectively treat symptoms of the disease at the targeted dose.

Serepta’s drug, eteplirsen, so far has seemed to be effective at treating symptoms of Duchenne. Clinical trials have taken place in the UK. On Aug. 7 the company released promising clinical trial information, which will form the basis of their application for US FDA approval in early 2014.

Duchenne is a severely debilitating form of muscular dystrophy. The recessive muscular degenerative disorder affects approximately 1 in 3,600 boys, and life expectancy for sufferers is usually around 25. A drug from either company would be the first on the American market designed to treat the disorder.

The London-based GlaxoSmithKline , which is the fourth largest pharmaceutical company in the world, shrugged off the setback. Their stock is up .33 percent to hit $51.70 a share.

Serepta is up 6.77 percent to hit $34.21 a share.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for GSK
MAISA
25 Jan 15 11:20:09
$GSK is working closely with the World Health Organization #WHO and Centers for Disease Control and Prevention on the design of Phase 3
MAISA
25 Jan 15 11:19:10
$GSK will be the first one ever to commence the first largest scale Phase 3 trial for #Ebola vaccine
MAISA
25 Jan 15 11:17:41
$GSK will soon be commencing the first large-scale clinical trial to assess the efficacy of an experimental #Ebola vaccine
Stockaholics
25 Jan 15 10:54:14
Our Penny Stock Picks Gained 968% In 5 Weeks! Get Our Next Pick Early: http://t.co/yQwzgQ7fmA $LFAP $GSK $ROX
Dan
25 Jan 15 08:48:55
$GSK high open interest range is 50.00 to 47.00 for option expiration 02/20/2015. http://t.co/9fu7JaWH8j
Dan
25 Jan 15 08:35:02
$GSK Max Pain = 45.00. Maturity = 02/20/2015. Previous close = 45.01. http://t.co/OKtZVz5JZa
number16
25 Jan 15 06:54:06
#GlaxoSmithKline $GSK (LSE) - Jan 25 2015 14:53 MONTHLY CHART (SPB) ---> http://t.co/NSwNpeCdrC - Fib levels
TalkMarkets
25 Jan 15 02:33:11
Dividend Stocks Beat Annuities In These Markets $GSK $MCD $UN http://t.co/GOER4peyTK
Stockaholics
24 Jan 15 22:26:14
Our Penny Stock Picks Gained 968% In 5 Weeks! Get Our Next Pick Early: http://t.co/yQwzgQ7fmA $LFAP $GSK $ROX
Stockaholics
24 Jan 15 18:15:09
Our Penny Stock Picks Gained 968% In 5 Weeks! Get Our Next Pick Early: http://t.co/RO0WvtHwHz $LFAP $GSK $ROX
Diana Winslow MSW
24 Jan 15 16:42:47
RT @biospace: GlaxoSmithKline's Ebola Vaccine Arrives in Liberia Today http://t.co/ukWYekYfBj $GSK #EbolaResponse @ebola_response @nytimesh…
FinSentS UK100
24 Jan 15 15:18:12
$GSK:LN Morningstar Issues A+ Credit Rating to GlaxoSmithKline plc (GSK) #GLAXOSMITHKLINE PLC http://t.co/OYvgpijR8n #LDN100
Stockaholics
24 Jan 15 14:17:58
Our Penny Stock Picks Gained 968% In 5 Weeks! Get Our Next Pick Early: http://t.co/yQwzgQ7fmA $LFAP $GSK $ROX
TalkMarkets
24 Jan 15 13:57:14
Dividend Stocks Beat Annuities In These Markets $GSK $MCD $UN http://t.co/GOER4peyTK
Marvin Clark
24 Jan 15 12:44:13
Friday Wrap $SPY $GE $MCD $UPS $GSK $SNE $EXPE http://t.co/24rNWP9CUw
TalkMarkets
24 Jan 15 12:44:11
Friday Wrap $SPY $GE $MCD $UPS $GSK $SNE $EXPE http://t.co/UbyORXyovo
InvestProfits
24 Jan 15 12:26:29
GlaxoSmithKline PLC (GSK) is -3% Away from 200 Day Moving Average http://t.co/vMsCsY2BQv $GSK #investor #stocks #investing
Stock Rocket
24 Jan 15 10:17:29
Our Penny Stock Picks Gained 968% In 5 Weeks! Get Our Next Pick Early: http://t.co/g5jpD7KSUX $LFAP $GSK $ROX
OTP Group
24 Jan 15 09:57:05
http://t.co/xmfWqkn0Sb DewDiligence: Partial credit :- ) $GSK had the Botox: DewDiligence http://t.co/rudJLm40KP #otCQB #NYSE #Nasdaq
Marvin Clark
24 Jan 15 09:38:37
Friday Wrap: Markets Here, There And Everywhere $SPY $GE $MCD $UPS $EXPE $XBTC $SNE $GSK $SABR http://t.co/px20XjREHe
TalkMarkets
24 Jan 15 09:38:37
Friday Wrap: Markets Here, There And Everywhere $SPY $GE $MCD $UPS $EXPE $XBTC $SNE $GSK $SABR http://t.co/zcffSvDnIf
Joseph Hopkins
24 Jan 15 08:51:52
Just like $HGSI, I maintain that $GSK buys $THRX this year. They already are a massive owner. I'll hold all $THRX shares throughout 2015.
usasingh11
24 Jan 15 07:49:49
$PBMD has unsusal bidder on level II for 20k and 10k but he is not buying on ask , @MaisaCorp @EXPstocktrader .Google Immutep and $GSK !!!
FinSentS UK100
24 Jan 15 07:17:31
$GSK:LN Morningstar Issues A+ Credit Rating to GlaxoSmithKline plc (GSK) #GLAXOSMITHKLINE PLC http://t.co/JRg1qJtWQM #LDN100
TalkMarkets
24 Jan 15 07:03:32
Shares Of Array Biopharma Soared As Much As 40% On News Of Novartis Deal $ARRY $NVS $GSK http://t.co/hY0P6nEelu
TalkMarkets
24 Jan 15 06:33:31
Array BioPharma And Pandora Deliver Big For Options Buyers $ARRY $P $NVS $GSK http://t.co/zQ88U0lJRE
Ticker Report
24 Jan 15 05:55:54
Morningstar Issues A+ Credit Rating to GlaxoSmithKline plc $GSK http://t.co/AU9ys8AllZ
Stock Rocket
24 Jan 15 05:53:36
Our Penny Stock Picks Gained 968% In 5 Weeks! Get Our Next Pick Early: http://t.co/wMEn6i1tkM $LFAP $GSK $ROX
Callum Thomas
24 Jan 15 03:58:30
Chart: @Sentifi_UK Interesting, first $GSK Ebola vaccine shipped to Liberia... http://t.co/km74aXgvcV http://t.co/cTQ0esUotH
US Banking News
24 Jan 15 03:47:06
Berenberg Bank Increases GlaxoSmithKline plc Price Target to GBX 1,620 $GSK http://t.co/adTGWlShb7
Stock Rocket
24 Jan 15 01:27:07
Our Penny Stock Picks Gained 968% In 5 Weeks! Get Our Next Pick Early: http://t.co/wMEn6i1tkM $LFAP $GSK $ROX
中津川亮
23 Jan 15 23:15:31
RT @pharmalot: Bristol-Myers is cutting jobs in China as drug makers rethink marketing practices.. http://t.co/QtRvwWewEY #pharma $BMY $GSK…
中津川亮
23 Jan 15 23:13:49
RT @fwpharma: ICYMI: GlaxoSmithKline reported to cut about 1000 staff in China http://t.co/WHe92gptkI $GSK #pharma
Sentifi UK Market
23 Jan 15 23:05:03
First GSK Ebola vaccine shipped to Liberia http://t.co/w7DWm8UAEe More about $GSK: http://t.co/U8RbFvlTLO $GSK #Ebola http://t.co/EV2xPlY50j
Sentifi UK Market
23 Jan 15 23:00:52
Today's TOP 10 Most Discussed $FTSE 100 Companies http://t.co/UusUflPcz0 $GSK $STJ $CCH $ULVR $BRBY $SPD $HMSO $AAL http://t.co/EOVtWSgaTE
TalkMarkets
23 Jan 15 18:29:12
Shares Of Array Biopharma Soared As Much As 40% On News Of Novartis Deal $ARRY $NVS $GSK http://t.co/hY0P6nEelu
Pharma Bro
23 Jan 15 18:25:11
First GSK #Ebola vaccine shipment arrived in Liberia today $GSK #pharma http://t.co/kwH06ASTpu http://t.co/qPgg7ZzHqp
Dr. Duru
23 Jan 15 18:02:34
Array BioPharma And Pandora Deliver Big For Options Buyers $ARRY $P $NVS $GSK http://t.co/omLKrx4Efq
TalkMarkets
23 Jan 15 18:02:32
Array BioPharma And Pandora Deliver Big For Options Buyers $ARRY $P $NVS $GSK http://t.co/zQ88U0lJRE
JQ
23 Jan 15 17:04:10
@chasingthealpha @AndyBiotech Not really, $GSK focus on epigenetics and immunooncology: http://t.co/d7GQYainyw
Jake13
23 Jan 15 16:23:30
Stocks Trending Now: http://t.co/j1I70Q28lk $BHLB $WAB $NOV $GRYCF $IO $WLHSF $MIICF $KYTH $WAC $GSK $REMI $RHHBF ~
D. Marie Hein
23 Jan 15 15:48:56
RT @ScripDonnaDC: GSK-NIAID Ebola vaccine arrives in Liberia; awaits trial http://t.co/kz7K4hQqqa #Ebola #NIH #NIAID $GSK $MRK $NLNK #phar…
Jolene Lau
23 Jan 15 15:35:27
RT @ScripDonnaDC: GSK-NIAID Ebola vaccine arrives in Liberia; awaits trial http://t.co/kz7K4hQqqa #Ebola #NIH #NIAID $GSK $MRK $NLNK #phar…
Donna Young
23 Jan 15 15:35:13
GSK-NIAID Ebola vaccine arrives in Liberia; awaits trial http://t.co/kz7K4hQqqa #Ebola #NIH #NIAID $GSK $MRK $NLNK #pharma #biotech #CDC
JQ
23 Jan 15 15:33:30
@AndyBiotech Wouldn't it be funny if $GSK is $ARRY's "experienced partner" for both binimetinib and encorafenib?
FinSentS UK100
23 Jan 15 15:20:20
$GSK:LN GlaxoSmithKline Pharmaceuticals surges over 10% on heavy volumes #GLAXOSMITHKLINE PLC http://t.co/CV1BiuTyJz #LDN100
Roy Friedman
23 Jan 15 15:04:37
.@CarlyHFierce @JohnCFierce Bexsero now belongs2 $GSK as a consequence of Apr2014 asset swap.
On Time Picks
23 Jan 15 15:04:07
DewDiligence: FDA approves $GSK/NVS’ Bexsero meningitis-B vaccine:: DewDiligence http://t.co/EQDe1UnNiD
Stock Rocket
23 Jan 15 14:53:54
Our Penny Stock Picks Gained 968% In 5 Weeks! Get Our Next Pick Early: http://t.co/wMEn6i1tkM $LFAP $GSK $ROX
Kelvin Lam
23 Jan 15 12:27:52
RT @biospace: GlaxoSmithKline's Ebola Vaccine Arrives in Liberia Today http://t.co/ukWYekYfBj $GSK #EbolaResponse @ebola_response @nytimesh…
				
				
  +Follow August 16, 2013 9:54AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.